Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival

Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival

Abstract Recent evidence has shed light on the significant role of FANCD2 in cancer initiation, development, and progression. However, a comprehensive pan-cancer analysis of FANCD2 has been lacking. In this study, we have conducted a thorough investigation into the expression profiles and prognostic...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Zedan Zhao, Ruyu Wang, Ruixue Wang, Jialing Song, Fengjun Ma, Huafeng Pan, Cuiyun Gao, Deqiang Wang, Xuemei Chen, Xiangzhen Fan
Natura:	Articolo
Lingua:	English
Pubblicazione:	BMC 2024-03-01
Serie:	BMC Medical Genomics
Soggetti:	FANCD2 Pan-cancer analysis Prognosis Immune infiltration Genetic alteration Enrichment analysis
Accesso online:	https://doi.org/10.1186/s12920-024-01836-4

Documenti analoghi

Correction: Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival
di: Zedan Zhao, et al.
Pubblicazione: (2024-05-01)

Microarray gene profiling analysis of glioblastoma cell line U87 reveals suppression of the FANCD2/Fanconi anemia pathway by the combination of Y15 and temozolomide
di: Zichuan Wang, et al.
Pubblicazione: (2019-06-01)

ATR-Mediated FANCI Phosphorylation Regulates Both Ubiquitination and Deubiquitination of FANCD2
di: Winnie Tan, et al.
Pubblicazione: (2020-02-01)

Expression Analysis of FANCD2 in Endometrial Carcinoma
di: Zhang L, et al.
Pubblicazione: (2024-12-01)

FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma
di: Xiaowei Tang, et al.
Pubblicazione: (2023-10-01)

Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma
di: Liying Song, et al.
Pubblicazione: (2022-06-01)

FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
di: Xujun Li, et al.
Pubblicazione: (2023-02-01)

Integrative analyses of prognosis, tumor immunity, and ceRNA network of the ferroptosis-associated gene FANCD2 in hepatocellular carcinoma
di: Zhihao Yang, et al.
Pubblicazione: (2022-09-01)

FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
di: D.V. Pilonetto, et al.
Pubblicazione: (2009-03-01)

ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
di: Sultana Parvin, et al.
Pubblicazione: (2023-04-01)

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma
di: Chenyang Ye, et al.
Pubblicazione: (2022-10-01)

Case report: Highly response to low-dose brachytherapy in recurrent retroperitoneal leiomyosarcoma with FANCD2 frameshift mutation: a unique case study
di: Xiao li Liu, et al.
Pubblicazione: (2024-04-01)

Lymphopenia With Clinical and Laboratory Features of Combined Immune Deficiency in an 11-Year-Old Female With FANCD2 Variants and Fanconi Anemia
di: Roman Deniskin, et al.
Pubblicazione: (2019-01-01)

FANCD2 limits acetaldehyde‐induced genomic instability during DNA replication in esophageal keratinocytes
di: Jasmine D. Peake, et al.
Pubblicazione: (2021-11-01)

Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid
di: Estefanía Burgos-Morón, et al.
Pubblicazione: (2016-07-01)

A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
di: Xuxue Guo, et al.
Pubblicazione: (2022-07-01)

Transcriptional profiling of Foxo3a and Fancd2 regulated genes in mouse hematopoietic stem cells
di: Xiaoli Li, et al.
Pubblicazione: (2015-06-01)

Replication stress increases mitochondrial metabolism and mitophagy in FANCD2 deficient fetal liver hematopoietic stem cells
di: Makiko Mochizuki-Kashio, et al.
Pubblicazione: (2023-03-01)

Citrinin Provoke DNA Damage and Cell-Cycle Arrest Related to Chk2 and FANCD2 Checkpoint Proteins in Hepatocellular and Adenocarcinoma Cell Lines
di: Darija Stupin Polančec, et al.
Pubblicazione: (2024-07-01)

Fancd2os Reduces Testosterone Production by Inhibiting Steroidogenic Enzymes and Promoting Cellular Apoptosis in Murine Testicular Leydig Cells
di: Xiang Zhai, et al.
Pubblicazione: (2022-06-01)

Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.
di: Chinnadurai Mani, et al.
Pubblicazione: (2021-09-01)

MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
di: Xiaoyu Zhang, et al.
Pubblicazione: (2021-11-01)

Upregulation of Ferroptosis-Related Fanconi Anemia Group D2 is a Poor Prognostic Factor and an Indicator of Tumor Immune Cell Infiltration in Lung Adenocarcinoma
di: Jingtao Zhang, et al.
Pubblicazione: (2022-05-01)

Role of SYT11 in human pan-cancer using comprehensive approaches
di: Kyunghee Noh, et al.
Pubblicazione: (2024-06-01)

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
di: Xiaoyu Zhang, et al.
Pubblicazione: (2021-12-01)

Deciphering the multidimensional impact of IGFBP1 expression on cancer prognosis, genetic alterations, and cellular functionality: A comprehensive Pan-cancer analysis
di: Zengwu Yao, et al.
Pubblicazione: (2024-09-01)

Clinical Validation of the Somatic FANCD2 Mutation (c.2022-5C>T) as a Novel Molecular Biomarker for Early Disease Progression in Chronic Myeloid Leukemia: A Case–Control Study
di: Nawaf Alanazi, et al.
Pubblicazione: (2024-07-01)

Prognostic and Immunological Role of Gasdermin E in Pan-Cancer Analysis
di: Zheng Zhang, et al.
Pubblicazione: (2021-07-01)

CRHBP, a novel multiple cancer biomarker connected with better prognosis and anti-tumorigenicity
di: Wonbeak Yoo, et al.
Pubblicazione: (2024-11-01)

Genetic Alteration, Prognostic and Immunological Role of Acyl-CoA Synthetase Long-Chain Family Member 4 in a Pan-Cancer Analysis
di: Yongsheng Yu, et al.
Pubblicazione: (2022-01-01)

Integrative Pan-Cancer Analysis Reveals Decreased Melatonergic Gene Expression in Carcinogenesis and RORA as a Prognostic Marker for Hepatocellular Carcinoma
di: Yi Zou, et al.
Pubblicazione: (2021-03-01)

A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors
di: Qiang Ding, et al.
Pubblicazione: (2023-11-01)

A human pan-cancer system analysis of regulator of chromatin condensation 2
di: Siming Gong, et al.
Pubblicazione: (2023-02-01)

Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer
di: Hui Deng, et al.
Pubblicazione: (2024-02-01)

The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis
di: Shoudu Zhang, et al.
Pubblicazione: (2023-09-01)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1)
di: Shuang Gao, et al.
Pubblicazione: (2021-11-01)

A pan-cancer study of ADAM9’s immunological function and prognostic value particularly in liver cancer
di: Mandana AmeliMojarad, et al.
Pubblicazione: (2024-11-01)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2
di: Qiqi Xu, et al.
Pubblicazione: (2022-05-01)

Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer
di: Huan Feng, et al.
Pubblicazione: (2020-09-01)

The Predictive Competing Endogenous RNA Regulatory Networks and Potential Prognostic and Immunological Roles of Cyclin A2 in Pan-Cancer Analysis
di: Shenyong Chen, et al.
Pubblicazione: (2022-04-01)